Key Takeaways
- • International Flavors & Fragrances (IFF) has agreed to divest its Food Ingredients business to CVC Capital Partners for approximately US$4.3 billion at a 10x enterprise value-to-EBITDA multiple, representing a significant portfolio optimization initiative.
- • IFF will retain a 10% minority equity stake in the Food Ingredients business valued at roughly US$200 million, ensuring continued strategic participation and exposure to future upside while maintaining innovation and supply chain collaboration.
- • The transaction reflects IFF's strategic pivot toward higher-growth, higher-margin segments including flavors, fragrances, and health & biosciences, enabling accelerated R&D investment and improved integration of biotechnology and naturals capabilities across its global platform.
- • The divestiture provides IFF with substantial capital flexibility and enhanced shareholder value while positioning the company for sustained, profitable long-term growth under a simplified, more focused portfolio structure.
- • The deal underscores broader M&A activity in the specialty chemicals and food ingredients sector during Q2 2026, with portfolio refocusing and private equity consolidation reshaping competitive dynamics in the space.
Summary
International Flavors & Fragrances announced a definitive agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners for approximately US$4.3 billion, representing a transformational step in the company's ongoing portfolio optimization strategy. The enterprise value-to-EBITDA multiple of approximately 10x reflects a strong valuation for the division, which produces texturants, emulsifiers, and sweetening solutions across the food ingredients market. Notably, IFF will retain a 10% minority equity stake valued at roughly US$200 million, positioning the company to remain strategically connected to the business while participating in future value creation under CVC's dedicated ownership.
The transaction directly supports IFF's stated strategic priority to concentrate resources on higher-growth, higher-margin business segments. By divesting the Food Ingredients division, IFF can accelerate innovation, increase R&D investment, and more effectively integrate its biotechnology and naturals capabilities across its global platform. CEO Erik Fyrwald emphasized that the divestiture allows IFF to "simplify our portfolio to where we can create the greatest value," while the retained minority stake ensures continuity on innovation collaboration, customer solutions, and supply chain synergies—critical interfaces that will benefit both the standalone Food Ingredients business under CVC ownership and IFF's core operations.
The retained 10% equity stake reflects a pragmatic approach to portfolio transformation. Rather than complete exit, IFF maintains exposure to a "strong business" that the company built over decades, creating the opportunity to capture upside as CVC implements its own operational and growth strategies. This structure also preserves institutional knowledge and operational linkages that are difficult to replicate through arm's-length contracts alone.
The deal generates substantial capital flexibility for IFF while delivering enhanced shareholder value through a combination of divestiture proceeds and ongoing equity participation. This capital can be deployed toward organic growth initiatives, acquisitions in higher-margin segments, or returned to shareholders. The transaction is consistent with broader sector trends in Q2 2026, where specialty chemicals and food ingredients companies are pursuing portfolio refocusing and private equity consolidation to sharpen competitive positioning and unlock trapped value in slower-growth divisions.
The transaction directly supports IFF's stated strategic priority to concentrate resources on higher-growth, higher-margin business segments. By divesting the Food Ingredients division, IFF can accelerate innovation, increase R&D investment, and more effectively integrate its biotechnology and naturals capabilities across its global platform. CEO Erik Fyrwald emphasized that the divestiture allows IFF to "simplify our portfolio to where we can create the greatest value," while the retained minority stake ensures continuity on innovation collaboration, customer solutions, and supply chain synergies—critical interfaces that will benefit both the standalone Food Ingredients business under CVC ownership and IFF's core operations.
The retained 10% equity stake reflects a pragmatic approach to portfolio transformation. Rather than complete exit, IFF maintains exposure to a "strong business" that the company built over decades, creating the opportunity to capture upside as CVC implements its own operational and growth strategies. This structure also preserves institutional knowledge and operational linkages that are difficult to replicate through arm's-length contracts alone.
The deal generates substantial capital flexibility for IFF while delivering enhanced shareholder value through a combination of divestiture proceeds and ongoing equity participation. This capital can be deployed toward organic growth initiatives, acquisitions in higher-margin segments, or returned to shareholders. The transaction is consistent with broader sector trends in Q2 2026, where specialty chemicals and food ingredients companies are pursuing portfolio refocusing and private equity consolidation to sharpen competitive positioning and unlock trapped value in slower-growth divisions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.